Internal Medicine, Clinical Cardiatric Electrophysiology · Petoskey, MI
NPI
1124049358
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
560 W Mitchell St, Suite 400
Petoskey, MI, 49770
Phone (231) 487-2490
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
3,389 prescriptions
Company payments, 2025
$106
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Peter E Levanovich prescribed most often to Medicare patients was Bisoprolol Fumarate, with 536 prescriptions and refills. In total Peter E Levanovich wrote 3,389 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-04-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Bisoprolol Fumarate Generic | 536 | 1,316 | 176 | $20K |
| Entresto Sacubitril/Valsartan | 402 | 772 | 103 | $456K |
| Xarelto Rivaroxaban | 341 | 709 | 82 | $378K |
| Spironolactone Generic | 337 | 829 | 114 | $4,294 |
| Eliquis Apixaban | 172 | 390 | 47 | $212K |
| Nebivolol Hcl Generic | 152 | 320 | 41 | $5,354 |
| Valsartan Generic | 139 | 335 | 43 | $5,081 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 125 | 325 | 40 | $3,355 |
| Losartan Potassium Generic | 84 | 231 | 28 | $1,210 |
| Digoxin Generic | 66 | 158 | 19 | $1,501 |
| Atorvastatin Calcium Generic | 62 | 183 | 26 | $898 |
| Metoprolol Succinate Generic | 60 | 178 | 23 | $1,231 |
| Eplerenone Generic | 58 | 152 | 19 | $5,152 |
| Rosuvastatin Calcium Generic | 56 | 169 | 18 | $928 |
| Midodrine Hcl Generic | 55 | 101 | 14 | $3,541 |
Brand drugs: - claims; generic drugs: 2,398 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter E Levanovich $106 ($106 in general payments such as food, travel and fees) from 3 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $47.9.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.